Search research articles
Contact Us
Filters
Showing results (191-200 of 201) with videos related to
Page
of 21
Sort By:
Science Translational Medicine
|
October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Antiviral Research
|
September 14, 2025
CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques
John J Suschak, Collin J Fitzpatrick, Charles J Shoemaker, et al.
Vaccines
|
May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial
Julie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Frontiers in Immunology
|
January 21, 2026
An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse models
Zachary R Stromberg, Elvia E Silva, Sara C Johnston, et al.
Cell
|
September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Eric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Viruses
|
May 28, 2022
Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model
Sandra L Bixler, Christopher P Stefan, Alexandra N Jay, et al.
Science Translational Medicine
|
April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses
Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2024
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa
Betty Mwesigwa, Fredrick Sawe, Janet Oyieko, et al.
Plos One
|
February 2, 2021
Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure
Sara C Johnston, Keersten M Ricks, Alexandra Jay, et al.
Vaccines
|
May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
Sara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 201) with videos related to
Sort By:
Page
of 21
Science Translational Medicine
|
October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Antiviral Research
|
September 14, 2025
CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques
John J Suschak, Collin J Fitzpatrick, Charles J Shoemaker, et al.
Vaccines
|
May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial
Julie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Frontiers in Immunology
|
January 21, 2026
An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse models
Zachary R Stromberg, Elvia E Silva, Sara C Johnston, et al.
Cell
|
September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Eric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Viruses
|
May 28, 2022
Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model
Sandra L Bixler, Christopher P Stefan, Alexandra N Jay, et al.
Science Translational Medicine
|
April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses
Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2024
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa
Betty Mwesigwa, Fredrick Sawe, Janet Oyieko, et al.
Plos One
|
February 2, 2021
Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure
Sara C Johnston, Keersten M Ricks, Alexandra Jay, et al.
Vaccines
|
May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
Sara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.
Page
of 21